Linzess denied due to quantity / dose limits by Aetna?

Aetna's specific coverage criteria for linzess are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Applies Quantity Limits to Linzess

Aetna imposes quantity limits on Linzess (linaclotide) as a formulary utilization-management measure. These limits cap how many capsules or how many days' supply will be covered in a given period. A quantity-limit denial typically means the prescription as written exceeds the quantity Aetna will authorize under its standard coverage policy. This does not mean the medication is inappropriate — it means the quantity or supply interval does not match Aetna's default parameters.

## Why This Denial Is Appealable

If your treating physician has determined that the standard covered quantity is clinically insufficient for your condition, that medical judgment is grounds for an exception appeal. Under ACA §2719, non-grandfathered plans must provide external review access. ERISA §503 applies to employer-sponsored plans. File an internal appeal within the deadline on the denial notice. External review must be requested within approximately four months of exhausting internal remedies. Expedited review is available for urgent clinical situations.

## The Concrete Appeal Process

1. Confirm the specific quantity limit: obtain from Aetna or the pharmacy benefit manager the exact quantity limit applied to Linzess on your plan. 2. Confirm the prescribed quantity: verify the prescription as written by the physician. 3. Determine the gap: document the difference and why the standard quantity is insufficient. 4. File an internal appeal requesting a quantity-limit exception with supporting clinical documentation. 5. Request external review if the internal appeal is denied.

## Documentation to Gather

• Prescriber's medical justification: a letter from the treating physician explaining the clinical rationale for the prescribed quantity — for example, a documented need for continuous daily therapy based on the severity and nature of the patient's IBS-C or CIC.
• Chart documentation of inadequacy: if a lower quantity was previously tried and found insufficient (e.g., patient ran out before the refill window), document dates and clinical consequences.
• Diagnosis and severity documentation: chart notes confirming the diagnosis and its impact on daily function.
• FDA-approved prescribing label: confirm the prescribed quantity falls within the dosing guidance in the label, and attach the relevant section.
• Aetna's quantity-limit policy: request the specific quantity-limit criteria for Linzess so you can respond to each requirement.

## Criteria-Mapping Structure

For a quantity-limit exception, the key argument is clinical necessity for the higher quantity. Structure the appeal as: (1) the standard limit Aetna applies; (2) the quantity the physician prescribed and why; (3) the chart evidence showing why the standard quantity is inadequate for this patient; (4) the FDA label confirming the prescribed quantity is within approved parameters. Attach supporting chart notes with dates. This direct structure addresses the specific grounds most likely to succeed at both internal appeal and external review.